Video: Large amounts of coffee consumption bad for under-55s

Drinking large amounts of coffee may be bad for under-55s, according to a recent study published in Mayo Clinic Proceedings. » Full article

Newly expanded role for Canadian pharmacists

Pharmacists in Canada were recently given broader responsibilities including, in certain provinces, prescribing privileges, vaccination abilities, and the ability to order and interpret laboratory tests. This newly expanded role for Canadian pharmacists can benefit both patients and physicians, according to an article in the Canadian Medical Association Journal.
» Full article

Insulin pumps vs injections for diabetic kids

Insulin pumps control blood sugar in children with diabetes better than insulin injections, according to a new study. » Full article

1 of 10 Americans have taken someone else's Rx

One in 10 Americans admit taking someone else's Rx, according to an ongoing Reuters/psos online survey. About a quarter of those people used the prescription drugs to get high, according to the survey. » Full article

Continuing Education

Final Pain Management CPE activity available now

The fifth Pain Management CPE activity, “Management of common pain medications encountered by pharmacists,” is available. It is the final article in our CPE series: Pain Management Considerations in Medication Therapy Management. Pharmacists can earn up to 10 credits by completing our April 2013 through August 2013 monthly knowledge-based activities.

To read and print the article with TEST QUESTIONS, click here. To proceed to the online exams and earn up to 2 CPE credits, click here to log in.

Announcement: Welcome to the new user registration process. This new process requires all pharmacists and pharmacy technicians to provide or update their NABP e-Profile ID in order to electronically keep track of CPE credits from ACPE-accredited providers. If you have not done so, you can obtain your NABP e-Profile ID now at www.MyCPEmonitor.net. This profile will enable you to have one login for all the NABP programs and services you will need throughout your career.

INFOGRAPH: Oral oncolytics: assessing value of newer agents versus current standards of care as part of P&T processes

This article offers formulary decision makers information needed to evaluate newer oral oncolytic therapies compared with existing standards of care using guidelines from the National Comprehensive Cancer Network®. The oral agents discussed are limited to those introduced into the market since 2007. » Full article

• Dietary fiber lowers risk of first stroke: Study

• Study shows patient satisfaction with pharmacy program

• Study finds that dapagliflozin produces similar glycemic efficacy to glipizide

• Unauthorized prescribers bill Part D $5 million

SURVEY

With a third new oral agent (Tecfidera) recently introduced for relapsing-remitting MS, how will the MS market look in the next 3-5 years?

— Orals will become the most frequently prescribed products

— Injectables will continue to dominate market share

— Equal split between orals and injectables

Click Here to let us know.

RESOURCES

Drug Watch

Latest Clinical News